Clinical trials
Active, not recruiting Phase 2/3 trials in Thailand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 3 |
| Hoffmann-La Roche | 2 |
| Regeneron Pharmaceuticals | 2 |
| Chulalongkorn University | 1 |
| Exelixis | 1 |
| GlaxoSmithKline | 1 |
| PENTA Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 |
| HIV Infections | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Breast Neoplasms | 1 |
| Hemarthrosis | 1 |
| Hemophilia A | 1 |
| Lung Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.